KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Moderna (MRNA) Assets Average (2019 - 2026)

Moderna (MRNA) has disclosed Assets Average for 8 consecutive years, with $11.9 billion as the latest value for Q1 2026.

  • For Q1 2026, Assets Average fell 11.25% year-over-year to $11.9 billion; the TTM value through Mar 2026 reached $11.9 billion, down 11.25%, while the annual FY2025 figure was $13.2 billion, 18.69% down from the prior year.
  • Assets Average hit $11.9 billion in Q1 2026 for Moderna, down from $12.2 billion in the prior quarter.
  • Across five years, Assets Average topped out at $26.8 billion in Q2 2022 and bottomed at $11.9 billion in Q1 2026.
  • Average Assets Average over 5 years is $18.8 billion, with a median of $17.6 billion recorded in 2024.
  • Year-over-year, Assets Average soared 160.99% in 2022 and then decreased 29.67% in 2024.
  • Moderna's Assets Average stood at $26.0 billion in 2022, then decreased by 27.04% to $18.9 billion in 2023, then decreased by 20.94% to $15.0 billion in 2024, then fell by 18.27% to $12.2 billion in 2025, then dropped by 2.64% to $11.9 billion in 2026.
  • According to Business Quant data, Assets Average over the past three periods came in at $11.9 billion, $12.2 billion, and $12.1 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.